Compile Data Set for Download or QSAR
Report error Found 61 Enz. Inhib. hit(s) with all data for entry = 50013860
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570373(CHEMBL4852939)
Affinity DataIC50: 200nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570375(CHEMBL4856507)
Affinity DataIC50: 200nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570372(CHEMBL4865889)
Affinity DataIC50: 300nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570360(CHEMBL4846103)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570361(CHEMBL4876723)
Affinity DataIC50: 1.80E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570368(CHEMBL4850204)
Affinity DataIC50: 2.30E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570369(CHEMBL4845765)
Affinity DataIC50: 2.60E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570371(CHEMBL4873132)
Affinity DataIC50: 2.80E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570370(CHEMBL4877782)
Affinity DataIC50: 2.90E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570380(CHEMBL4878322)
Affinity DataIC50: 3.30E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570367(CHEMBL4862067)
Affinity DataIC50: 3.70E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570364(CHEMBL4852089)
Affinity DataIC50: 4.50E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570363(CHEMBL4850092)
Affinity DataIC50: 6.20E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570374(CHEMBL4877055)
Affinity DataIC50: 6.60E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570365(CHEMBL4874060)
Affinity DataIC50: 7.10E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570359(CHEMBL4850600)
Affinity DataIC50: 8.70E+3nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570378(CHEMBL4868376)
Affinity DataIC50: 1.13E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570359(CHEMBL4850600)
Affinity DataIC50: 1.33E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570376(CHEMBL4846484)
Affinity DataIC50: 1.37E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570362(CHEMBL4862279)
Affinity DataIC50: 1.43E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570378(CHEMBL4868376)
Affinity DataIC50: 1.45E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570380(CHEMBL4878322)
Affinity DataIC50: 1.61E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570361(CHEMBL4876723)
Affinity DataIC50: 1.67E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570379(CHEMBL4877472)
Affinity DataIC50: 1.69E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570365(CHEMBL4874060)
Affinity DataIC50: 1.70E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570379(CHEMBL4877472)
Affinity DataIC50: 1.85E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570366(CHEMBL4877760)
Affinity DataIC50: 2.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570376(CHEMBL4846484)
Affinity DataIC50: 2.26E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570371(CHEMBL4873132)
Affinity DataIC50: 2.79E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570374(CHEMBL4877055)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570375(CHEMBL4856507)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570377(CHEMBL4878209)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570363(CHEMBL4850092)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570362(CHEMBL4862279)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570361(CHEMBL4876723)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570360(CHEMBL4846103)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570359(CHEMBL4850600)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570364(CHEMBL4852089)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570365(CHEMBL4874060)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570366(CHEMBL4877760)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetTumor necrosis factor(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570367(CHEMBL4862067)
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of TNFalpha (unknown origin) in HEK-Blue-hTLR2 cells assessed as inhibition of TNFalpha-induced NFkappaB activation pretreated for 2 hrs f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570360(CHEMBL4846103)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570362(CHEMBL4862279)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570363(CHEMBL4850092)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570364(CHEMBL4852089)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570366(CHEMBL4877760)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570367(CHEMBL4862067)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570368(CHEMBL4850204)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570369(CHEMBL4845765)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
TargetToll-like receptor 2(Human)
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570370(CHEMBL4877782)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam2CSK4-induced TLR2/TLR6 activation by measuring decrease i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2022
Entry Details Article
PubMed
Displayed 1 to 50 (of 61 total ) | Next | Last >>
Jump to: